Earnings roundup
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
UCSB joins NSF’s National Quantum Virtual Laboratory
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
TTD reports strong Q3 to stabilize stock
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AppFolio shares recover after big selloff from earnings miss
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sovato raises $26M in Series B round
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen delivers earnings beat in Q3
Thousand Oaks-based Amgen delivered a sound third-quarter earnings beat when it announced financial results on Nov. 4, highlighting big sales beats from blockbuster drugs Repatha and Prolia. Amgen, one of the largest biotechnology companies in the world, announced that revenue for the quarter ended Sept. 30 reached $9.6 billion, a 12% year-over-year increase, driven by Read More →
Amgen holds virtual groundbreaking for planned $600M science center
Hard hats on, shovels in hand, Amgen executives and elected officials held an Oct. 30 virtual groundbreaking for a planned $600 million science and innovation center on the biotech giant’s sprawling Thousand Oaks campus. Announced in September, the proposed structure hasn’t yet been green-lighted by the city. It has just started to make its way Read More →
